Likarda
Likarda
Roche’s $50B US Boost: Jobs and Growth Ahead!
BIOT
Roche is investing $50B in U.S. manufacturing and R&D, creating jobs and addressing looming tariffs! 🇺🇸🏭📈 Biopharma Investment
Revolutionizing Cell Therapy: Likarda and Cold Chain Technologies Join Forces
BIOT
🚚🧪 Likarda and Cold Chain Technologies join forces to revolutionize cell therapy manufacturing with advanced logistics solutions.
Revolutionary Cell Transport Tech: No Cryopreservation Needed!
BIOT
📰 Likarda, a company spun out of the University of Kansas, revolutionizes cell transportation with Core-Shell Spherification, eliminating cryopreservation. 👩🔬🔬👨🔬
